4.5 Article

Development and validation of a clinical and genetic model for predicting risk of severe COVID-19

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Medicine, General & Internal

Genetic Variants of SARS-CoV-2-What Do They Mean?

Adam S. Lauring et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Multidisciplinary Sciences

Genetic mechanisms of critical illness in COVID-19

Erola Pairo-Castineira et al.

Summary: In critically ill patients with COVID-19, host genetic variants associated with antiviral defense mechanisms and inflammatory organ damage were identified through a genome-wide association study. These genetic signals provide potential targets for therapeutic development and repurposing of existing drugs. Large-scale randomized clinical trials will be essential to confirm the effectiveness of targeted treatment strategies.

NATURE (2021)

Article Pediatrics

Rare Genetic Variants in Immune Genes and Neonatal Herpes Simplex Viral Infections

Lauren Cummings et al.

Summary: This study investigated the genetic basis of neonatal herpes simplex virus (HSV) infection and identified potentially deleterious variants in genes related to HSV immunity and response. These findings provide valuable insights into understanding neonatal susceptibility to HSV.

PEDIATRICS (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells

Shiv Bharadwaj et al.

Summary: Researchers suggest that SARS-CoV-2 infection may require an escalation in anabolic metabolism, such as glucose and glutamine, to support energy and biosynthetic requirements, potentially involving key cellular factors like GLS1, PSAT1, HIF-1 alpha, mTORC1, GFAT1/2, and Myc. Further studies are needed to clarify the role of dysregulated glutamine metabolism in SARS-CoV-2 pathogenesis and explore therapeutic development strategies.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Review Medicine, General & Internal

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Olivier J. Wouters et al.

Summary: The COVID-19 pandemic may not end globally until vaccines that protect against severe disease and drive herd immunity are widely distributed. While vaccines have been authorized for human use in many countries, achieving global control of COVID-19 requires not only licensed vaccines but also mass production, affordable pricing, global allocation, and wide local deployment.

LANCET (2021)

Article Multidisciplinary Sciences

An integrated clinical and genetic model for predicting risk of severe COVID-19: A population-based case-control study

Gillian S. Dite et al.

Summary: The study found that age and gender are not the main factors contributing to the risk of severe COVID-19, but rather other risk factors. By developing a model that includes single-nucleotide polymorphisms and clinical risk factors, the risk of severe COVID-19 can be more accurately predicted.

PLOS ONE (2021)

Article Multidisciplinary Sciences

Modeling the effect of lockdown timing as a COVID-19 control measure in countries with differing social contacts

Tamer Oraby et al.

Summary: A stochastic continuous-time Markov chain model was developed to analyze the effects of lockdown timing during a pandemic, showing that well-timed lockdowns can effectively reduce peak incidence, extend the duration of the pandemic, and prevent overwhelming hospital capacity.

SCIENTIFIC REPORTS (2021)

Article Genetics & Heredity

Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity

Janie F. Shelton et al.

Summary: A study of over one million 23andMe research participants identified genetic and nongenetic associations with COVID-19 susceptibility and severity. The research found a strong association between blood type, a gene-rich locus on chromosome 3p21.31, and COVID-19 diagnosis and outcome severity.

NATURE GENETICS (2021)

Article Public, Environmental & Occupational Health

Criteria for returning to work and determination of the vulnerability value for Covid-19

Rebeca Velasco-Reyna et al.

Summary: Vulnerable groups such as obese individuals, the elderly, diabetes, and hypertension have an increased risk of developing severe Covid-19, necessitating specific medical conditions and epidemiological risk levels for safe return to work.

SALUD PUBLICA DE MEXICO (2021)

Article Multidisciplinary Sciences

Structural analysis of TIFA: Insight into TIFA-dependent signal transduction in innate immunity

Teruya Nakamura et al.

SCIENTIFIC REPORTS (2020)

Editorial Material Medicine, General & Internal

Covid-19: risk factors for severe disease and death

Rachel E. Jordan et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Article Medicine, General & Internal

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

David Ellinghaus et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Developmental Biology

GATA transcription factors in development and disease

Mathieu Tremblay et al.

DEVELOPMENT (2018)

Article Multidisciplinary Sciences

The UK Biobank resource with deep phenotyping and genomic data

Clare Bycroft et al.

NATURE (2018)

Review Immunology

GATA-3 Function in Innate and Adaptive Immunity

Irma Tindemans et al.

IMMUNITY (2014)